2008
DOI: 10.1016/j.jmb.2007.11.053
|View full text |Cite
|
Sign up to set email alerts
|

cGMP-binding Prepares PKG for Substrate Binding by Disclosing the C-terminal Domain

Abstract: Type I cyclic guanosine 3',5'-monophosphate (cGMP)-dependent protein kinase (PKG) is involved in the nitric oxide/cGMP signaling pathway. PKG has been identified in many different species, ranging from unicelölular organisms to mammals. The enzyme serves as one of the major receptor proteins for intracellular cGMP and controls a variety of cellular responses, ranging from smooth-muscle relaxation to neuronal synaptic plasticity. In the absence of a crystal structure, the three-dimensional structure of the homo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

5
88
1

Year Published

2008
2008
2015
2015

Publication Types

Select...
8
2

Relationship

3
7

Authors

Journals

citations
Cited by 73 publications
(94 citation statements)
references
References 73 publications
5
88
1
Order By: Relevance
“…One potentially confusing finding is that Rp-8AET-cGMPS, which inhibits PKGI kinase activity by preventing disengagement of the kinase and autoinhibitory sites, also disrupts normal LZ-dependent PKGI␣-RhoA binding. Others have shown, however, that liberation of the PKI␣ kinase domain from the autoinhibitory site leads to increased solubility of the LZ domain (25). Therefore, we interpret our findings to support that cGMP-mediated positioning of the PKGI␣ LZ domain, as well as its kinase activating effect, mediates PKGI␣ RhoA binding.…”
Section: Discussionsupporting
confidence: 83%
“…One potentially confusing finding is that Rp-8AET-cGMPS, which inhibits PKGI kinase activity by preventing disengagement of the kinase and autoinhibitory sites, also disrupts normal LZ-dependent PKGI␣-RhoA binding. Others have shown, however, that liberation of the PKI␣ kinase domain from the autoinhibitory site leads to increased solubility of the LZ domain (25). Therefore, we interpret our findings to support that cGMP-mediated positioning of the PKGI␣ LZ domain, as well as its kinase activating effect, mediates PKGI␣ RhoA binding.…”
Section: Discussionsupporting
confidence: 83%
“…1a), and it has been previously identified as a critical control unit for auto-inhibition and cGMP selectivity in PKG I␤ (17,18). In addition, we examined the CNB-B domain because although the CNB-A domain contributes to the cyclic nucleotide modulation of PKG I function (17,(35)(36)(37), the CNB-A domain undergoes only minor structural changes upon cyclic nucleotide binding (2,17). We found that the partial agonism of cAMP cannot be explained by a simple reversal of the two-state inactive/active conformational equilibrium that rationalizes cGMP activation (2,17).…”
mentioning
confidence: 99%
“…In one example of this, the application of IMS to the 11-membered TRAP complex, which was shown to retain its ring topology after the electrospray process, and that the binding of tryptophan aided in the preservation of this complex [37]. A more recent application of a traveling wave IMS instrument was to the analysis of active and inactive forms of the (cGMP)-dependant protein kinase by the Heck group [38]. Results obtained from this experiment suggest that the active cGMP bound protein adopts larger cross-sections than the inactive apo-protein, consistent with the expected opening of the structure implied by the HDX experiments conducted in the same study.…”
mentioning
confidence: 99%